User profiles for Nathalie Auger

Nathalie Auger

University of Montreal
Verified email at inspq.qc.ca
Cited by 6538

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis

SQ Wei, M Bilodeau-Bertrand, S Liu, N Auger - Cmaj, 2021 - Can Med Assoc
Background: The impact of coronavirus disease 2019 (COVID-19) on maternal and newborn
health is unclear. We aimed to evaluate the association between severe acute respiratory …

High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial

…, S Postel-Vinay, Y Loriot, C Even, I Breuskin, N Auger… - Cancer discovery, 2017 - AACR
High-throughput genomic analyses may improve outcomes in patients with advanced cancers.
MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this approach. …

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

E Marangoni, A Vincent-Salomon, N Auger… - Clinical cancer …, 2007 - AACR
Purpose: To establish a panel of human breast cancer (HBC) xenografts in immunodeficient
mice suitable for pharmacologic preclinical assays. Experimental Design: 200 samples of …

[PDF][PDF] Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK-Positive Non–Small-Cell Lung Cancer

…, A Barthélémy, M Oulhen, N Auger… - Journal of clinical …, 2013 - researchgate.net
Purpose The diagnostic test for ALK rearrangement in non–small-cell lung cancer (NSCLC)
for crizotinib treatment is currently done on tumor biopsies or fine-needle aspirations. We …

[HTML][HTML] Molecular profiling of patient-derived breast cancer xenografts

…, C Guyader, C Decraene, C Lucchesi, N Auger… - Breast cancer …, 2012 - Springer
Introduction Identification of new therapeutic agents for breast cancer (BC) requires preclinical
models that reproduce the molecular characteristics of their respective clinical tumors. In …

[HTML][HTML] Clinical and translational implications of RET rearrangements in non–small cell lung cancer

R Ferrara, N Auger, E Auclin, B Besse - Journal of Thoracic Oncology, 2018 - Elsevier
Since the discovery in 2012 of rearranged during transfection proto-oncogene gene (RET)
rearrangements in NSCLC, at least 12 different fusion variants have been identified, with …

Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features

…, P Saulnier, JG Judde, JL Janneau, N Auger… - Cancer research, 2007 - AACR
Obtaining representative human colon cancer cell lines from fresh tumors is technically difficult.
Using 32 tumor fragments from patients with colon cancer, the present study shows that …

[PDF][PDF] Accumulation of segmental alterations determines progression in neuroblastoma

…, G Pierron, V Mosseri, A Valent, N Auger… - Journal of Clinical …, 2010 - researchgate.net
Purpose Neuroblastoma is characterized by two distinct types of genetic profiles, consisting
of either numerical or segmental chromosome alterations. The latter are associated with a …

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

…, I Di Mauro, J Rapp, G Pierron, N Auger… - The Lancet …, 2016 - thelancet.com
Background Advances in molecular genetics of sarcoma have enabled the identification of
type-specific aberrations. We aimed to assess the clinical effect of systematic implementation …

Association between preeclampsia and congenital heart defects

N Auger, WD Fraser, J Healy-Profitós, L Arbour - Jama, 2015 - jamanetwork.com
Importance The risk of congenital heart defects in infants of women who had preeclampsia
during pregnancy is poorly understood, despite shared angiogenic pathways in both …